Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Clinical OutsourcingClinical Outsourcing
Not Confirmed
Not Confirmed
03-04 March, 2026
Natural Product Expo W...Natural Product Expo West
Not Confirmed
Not Confirmed
03-06 March, 2026
Natural Products ExpoNatural Products Expo
Not Confirmed
Not Confirmed
03-06 March, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS





Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Clinical OutsourcingClinical Outsourcing
Industry Trade Show
Not Confirmed
03-04 March, 2026
Natural Product Expo W...Natural Product Expo West
Industry Trade Show
Not Confirmed
03-06 March, 2026
Natural Products ExpoNatural Products Expo
Industry Trade Show
Not Confirmed
03-06 March, 2026
Digital content

10 Dec 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/12/10/3202925/0/en/Bioxodes-raises-5-5-million-Series-A-extension-to-continue-preparations-for-pivotal-trial-of-breakthrough-stroke-candidate.html

14 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/14/3188030/0/en/Bioxodes-presents-BIOX-101-clinical-data-showing-breakthrough-potential-for-stroke-in-webcast-with-Prof-Dr-Robin-Lemmens.html

07 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/07/3162233/0/en/Bioxodes-appoints-industry-veteran-Philippe-Monteyne-as-chairman-as-it-accelerates-late-stage-development-of-breakthrough-stroke-candidate.html

11 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/11/3148338/0/en/Bioxodes-positive-Phase-2a-stroke-data-show-breakthrough-potential-of-innovative-therapeutic-candidate-BIOX-101.html

24 Apr 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/bioxodes-halts-phase-2-stroke-trial-after-successful-interim-review-plots-registrational

05 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/05/3037134/0/en/Bioxodes-obtains-Orphan-Drug-Designation-for-hemorrhagic-stroke-therapeutic-candidate-in-US-and-Europe.html
ABOUT THIS PAGE